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Abstract
Clinical and preclinical studies have shown that patients with Diabetic Neuropathy Pain (DNP) present with increased
tumor necrosis factor alpha (TNF-α) serum concentration, whereas studies with diabetic animals have shown that TNF-
α induces an increase in NaV1.7 sodium channel expression. This is expected to result in sensitization of nociceptor
neuron terminals, and therefore the development of DNP. For further study of this mechanism, dissociated dorsal root
ganglion (DRG) neurons were exposed to TNF-α for 6 h, at a concentration equivalent to that measured in STZ-induced
diabetic rats that developed hyperalgesia. Tetrodotoxin sensitive (TTXs), resistant (TTXr) and total sodium current was
studied in these DRG neurons. Total sodium current was also studied in DRG neurons expressing the collapsin
response mediator protein 2 (CRMP2) SUMO-incompetent mutant protein (CRMP2-K374A), which causes a significant
reduction in NaV1.7 membrane cell expression levels. Our results show that TNF-α exposure increased the density of
the total, TTXs and TTXr sodium current in DRG neurons. Furthermore, TNF-α shifted the steady state activation and
inactivation curves of the total and TTXs sodium current. DRG neurons expressing the CRMP2-K374A mutant also
exhibited total sodium current increases after exposure to TNF-α, indicating that these effects were independent of
SUMOylation of CRMP2. In conclusion, TNF-α sensitizes DRG neurons via augmentation of whole cell sodium current.
This may underlie the pronociceptive effects of TNF-α and suggests a molecular mechanism responsible for pain
hypersensitivity in diabetic neuropathy patients.
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Introduction
The World Health Organization (WHO) defines diabetes
as a chronic disease that results from poor insulin produc-
tion or the inability of the body to use it efficiently. As a
result, basal glucose concentration in the bloodstream
rises, resulting in hyperglycemia [1] According to esti-
mates, 9% of the world’s population over 18 years old are
affected by diabetes [2], while around 1.6 million deaths
were caused directly by diabetes, in 2016 [3]. The WHO
projection points out that, by 2030, diabetes will be the
7th major cause of death in the world [4]. Patients with
diabetes suffer from macrovascular complications, such as
myocardial infarction, stroke, peripheral vascular disease,
microvascular complications that manifest as peripheral
neuropathy, retinopathy and nephropathy [5]. Diabetes is
the main cause of peripheral neuropathy [6]. Among the
various types of diabetic neuropathy, the most common
clinical manifestation is distal symmetric polyneuropathy,
also called peripheral diabetic neuropathy (PDN), which
affects 75% of patients with diabetic neuropathy [7]. Ap-
proximately 20 to 30% of patients with PDN suffer from
diabetic neuropathic pain (DPN), one of the main clinical
consequences of PDN [8, 9].
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Studies in Streptozotocin (STZ)-induced diabetic rats
show that the development of hyperalgesia presented by
these animals is associated with an increased expression of
voltage-dependent sodium (NaV) channels [10, 11]. In
addition, patch clamp recordings indicated increased TTX-
sensitive sodium current density consistent with increased
expression of the NaV1.3, 1.6 and 1.7 isoforms [12–14].
Among these, the NaV1.7 isoform has been directly linked
to diabetic neuropathy and the release of proinflammatory
cytokines [11, 15–17]. These channels are mostly expressed
in small diameter Aδ and C fibers [18] and, not surpris-
ingly, in 85% of functionally identified nociceptors [19]. In
addition, NaV1.7 expression is increased in DRG neurons of
STZ-induced diabetic rats, a change that contributes to
pain-related hypersensitivity [11, 16, 20]. In PDN, increased
tumor necrosis factor α (TNF-α) expression in dorsal root
ganglion (DRG) neurons was linked to increased Nav 1.7
levels and nociceptive behaviors.
Here, we first determined the TNF-α serum concentra-
tion in a rat model of PDN and then assessed, for the first
time, the effects of this specific and physiologically rele-
vant concentration on whole cell sodium currents in DRG
neurons from normoglycemic rats. Then, we investigated
whether manipulating a recently reported NaV1.7 traffick-
ing regulator, the collapsin response mediator protein 2
(CRMP2) [21], could normalize the TNF-α mediated in-
crease in NaV1.7 function. CRMP2 is a cytosolic phospho-
protein that is dysregulated in neuropathic pain [8, 22]. Its
function as a trafficking regulator for NaV1.7 [21, 23, 24]
was suggested to be instrumental in regulating allodynic
and hyperalgesic behaviors in various rodent models of
pain [5, 6]. When SUMOylated, CRMP2 protects NaV1.7
from endocytosis thus maintaining the availability of the
channel for voltage-dependent activation and nociceptive
transmission [22, 23]. Inhibition of CRMP2 SUMOylation
efficiently decreased NaV1.7 surface localization and cur-
rents [25]. Thus, we hypothesized that inhibiting CRMP2
SUMOylation might reverse the increased NaV1.7 cur-
rents induced by TNF-α. However, as we show here, al-
though TNF-α increases sodium current density, these
effects occur independently of CRMP2 SUMOylation.
Materials and methods
Experiments were approved by the Institutional Animal
Care and Use Committee from the Federal University of
Minas Gerais (protocol number 233/2013) and by the
Health Sciences Animal Care Committee, from the Uni-
versity of Calgary (protocol number #AC13–0045).
Induction of experimental diabetes
28 day old male Wistar rats were randomly assigned to
both the diabetic and control groups. Rats in the diabetic
group were fasted overnight before receiving a single in-
traperitoneal injection of STZ solution (65 mg/kg diluted
in a 10mM sodium citrate buffer solution, pH of 4.5)
[26]. Rats in the control group received only sodium cit-
rate buffer solution. As shown by Junod et al. [27], this
single STZ dose induces a severe hypoglycemic state
within 7 hours, and this matches the time course of de-
velopment of hyperinsulinemia. Following STZ injection,
waterers containing a 10% glucose solution were placed
in the rat cages to reduce or prevent hyperinsulinemia
and hypoglycemic shock [28]. Glycemia levels were
assessed using blood samples (Accu-Check Active®,
Roche) obtained immediately before STZ injection (day
0), and then monitored fortnightly until the day 60 after
diabetes induction. Animals with blood glucose levels
over 300 mg/dl were considered diabetic.
Evaluation of mechanical hyperalgesia
Mechanical hyperalgesia was assessed by the use of a
Randall–Selitto device (Ugo-basile, 37,215, Verase, Italy),
through which an increasing pressure (32 g/s) was applied to
the dorsal portion of the rats’ back paws. The force (g) that
led the rat to withdraw its paw was considered as the mech-
anical nociceptive threshold. The increasing pressure cutoff
was set at 250 g to prevent tissue damage [22].
Quantification of TNF-α by ELISA
At the day before and at day 60 after STZ injection, 0.5
to 1.5 ml of blood samples were collected from the rats’
arterial tails by using a peripheral intravascular catheter
(24G needle) perfused with sodium citrate (1 mM) to
avoid coagulation during blood collection. Samples were
kept at room temperature for 10 min, followed by re-
frigeration (4 °C) for 10 min to form the clot to obtain
serum blood. The samples were then centrifuged (1300
RPM, 5 min) and the supernatant was collected. Plasma
concentration of TNF-α was quantified with rat-specific
ELISA kits (DuoSet kits; R&D Systems) using the Ther-
moscientific Multiskan FC. Kits were used in accordance
with manufacturer’s instructions.
DRG neuron dissociation
Sprague-Dawley rats (5–6 weeks old) were anesthetized
with isoflurane and decapitated by the use of guillotine.
After access to the spinal cord, 40–50 DRGs were asep-
tically dissected from cervical, thoracic and lumbar
spinal segments, and kept in ice-cold PBS (in mM: 137
NaCl2, 2.7 KCl, 10 Na2HPO4 and 2 KH2PO4). After
cleaning, DRGs were subjected to enzymatic digestion.
To that end, they were exposed to 1ml of F12 culture
medium solution (supplemented with 10% v/v fetal bo-
vine serum and 1% v/v penicillin-streptomycin solution)
with the addition of 40 μl of papain and 4mg of collage-
nase type 1 for 30min (Invitrogen), kept in a water bath at
37 °C. The DRGs were slightly shaken every 5min. Then
the medium was replaced for the addition of 0.4% type IV
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DNAse (Sigma). The DRGs were kept for another 10min
in the water bath. After digestion, the culture medium was
replaced 3 times in order to eliminate the digestive en-
zymes. DRGs were cautiously thinned by the use of a
1000 μl auto-pipette and the neurons were transferred to a
supplemented F12 culture medium (B27 (2%), L-glutamine
(1%), N2 (1%) and NGF (0.1%), Gibco). The dissociated
DRG neurons were then distributed into a 24-well plate
containing coverslips pretreated with laminin (1%) and
Poly-D-lysine (10%). 600 μl of medium containing cells was
added to each well. The 24-well plate was kept in the incu-
bator (5% CO2–95% O2, 37 °C) until the cells were used.
For the study of the TNF-α effect on the total sodium
current in transfected DRG neurons, the cells were kept in
culture for a period of 2 weeks. For the study of the effect
of TNF-α on the TTXs and TTXr sodium currents, cells
were used after a minimum time period of 12 h in culture.
Virus production for infection of dissociated DRG neurons
For the infection of the dissociated DRG neurons, the
AAV5 recombinant adenovirus (AAV5 Helper-Free Sys-
tem, Agilent Technologies Stratagene Products Division,
CA, USA) kit was used. The kit contains three vectors:
pAAV-MSC, pAAV-RC5 and pHelper. The first vector
contained the genes of interest, CRMP2-WT and
CRMP2-K374A, both tagged with GFP (Green Fluores-
cent Protein). These constructs were transfected into im-
mortalized cells of the 293AAV line (by the use of calcium
phosphate buffer solution) concomitantly with the vectors
pAAV-RC5 and pHelper, a process that results in the pro-
duction of viruses specific for infection of DRG neurons
and containing the constructs of interest, CRMP2-WT-
GFP and CRMP2-K374A-GFP, as viral materials. 24–72 h
post-transfection, the viruses were extracted from the
293AAV cells accordingly with the instructions of a virus
purification kit (Takara AAVpro® Purification Kit,
TAKARA BIO INC), resulting in solutions containing
5∙107 virus Gc/μl (genomic copies per microliter).
DRG neuron infection
12–18 h after dissociation of the DRG neurons, 5 μl of so-
lution containing the GFP-CRMP2-WT virus or 10 μl of
solution containing the GFP-CRMP2-K374A virus was
added to each well. Viruses were maintained in the culture
for 72 h, after which the medium was replaced for a B27
(2%), L-glutamine (1%), N2 (1%) and NGF supplemented
F12 medium. After 2 weeks in culture, successfully in-
fected neurons emitted GFP fluorescence (Zeiss LSM-510,
λ = 488 nm), confirming that they expressed the plasmid.
For the study of the TNF-α exposure effect on the
total Na+ current in infected cells, TNF-α (TNF Recom-
binant Rat Protein, Thermo Fisher Scientific) was added
to the culture medium at a concentration of 700 pg/ml
for 6 h, after which the cells had measured their total
Na+ current in a Patch Clamp platform.
Fig. 1 Glucose level and behavioral analysis in diabetic rats. a
Glycemia values measured biweekly. n represents the number of
rats * p < 0.05 control vs diabetic; Two Way ANOVA test
followed by Bonferroni. b Mechanical thresholds measured
biweekly. * p < 0.05 control vs diabetic. Two Way ANOVA test
followed by Bonferroni. c TNF-α serum concentration dosage in
the Control and Diabetic group for both day 0 and 60. n reflects
numbers of rats. * p < 0.05 control vs diabetic; One Way ANOVA
test followed by Bonferroni
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Electrophysiology
The total Na+ current was recorded by using the ampli-
fier Axoclamp 200B in the whole cell voltage clamp con-
figuration in combination with the Clampex 9.2 software
(Molecular Devices, Sunnyvale, CA). Low resistance
patch electrodes (3–4MΩ) were filled with solution con-
taining (in mM): 10 NaCl, 100 CsCl, 5 MgCl2, 10 HEPES
and 11 EGTA and 10 TEA-Cl, pH 7.2 adjusted with 1M
CsOH. 10 NaCl, 100 CsCl, 5 MgCl2, 10 HEPES and 11
EGTA and 10 TEA-Cl, pH 7.2 adjusted with 1M CsOH.
Cells were initially kept in a bath solution containing (in
mM): 50 NaCl, 5 CsCl, 0.1 CdCl2, 0.5 MgCl2, 60 Glucose
and 5 HEPES, pH 7.4 adjusted with 1M NaOH. After
reaching the whole cell configuration, the cell was per-
fused with external solution containing (in mM): 40
NaCl, 3 KCl, 1 CaCl2, 1 MgCl2, 0.1 CdCl2, 20 TEA-Cl,
70 Choline-Cl, 10 HEPES and 10 Glucose, pH 7.4 ad-
justed with 1M HCl/NaOH. Liquid junction potentials
between internal and bath solutions (− 0.5 mV) and be-
tween internal and external solutions (4.8 mV) were cor-
rected before any recordings. An Ag-AgCl electrode was
used as reference. The recordings were filtered with a
Bessel lowpass filter set at 2.9 kHz and digitalized at a
20 kHz (50 μs interval) through a Digidata 1320A inter-
face board. Capacitive currents were electronically com-
pensated and a P/4 protocol was used for correction of
the linear leakage current and for the subtraction of the
residual capacitance [24]. The experiments were carried
out on a petri acrylic plate, 35 mm in diameter, using an
inverted microscope (Nikon TMF- 100, Nikon, Japan).
For patch clamp experiments involving the acute effect
of TNF-α exposure, Na+ current recordings were ob-
tained by using the Patch Clamp amplifiers type EPC-9/
EPC-10 (HEKA Instruments, Germany) and the PULSE/
PATCHMASTER data acquisition program (HEKA In-
struments, Germany) adjusted for the whole cell voltage
clamp configuration. Low resistance patch electrodes
(3–4MΩ) were filled with the same pipette solution
mentioned before, as well as the bath/external solution.
An Ag- AgCl was used as a reference. Capacitive cur-
rents were electronically compensated and a P/4 proto-
col was used to correct the linear leakage current and to
subtract residual capacity [24]. The current recordings
were filtered with a Bessel lowpass filter set at 2.9 kHz
and acquired at a rate of 20 kHz (50 μs interval) through
an AD/DA interface (ITC 1600). The experiments were
performed on 35 mm diameter acrylic Petri dishes using
inverted microscope (Axiovert 20, Carl Zeiss, Germany
or Nikon TMF-100, Nikon, Japan). To record the TTXr
current, after establishing the whole cell configuration
and obtaining the total Na+ current, 100 μl of TTX-
containing external solution was added to the bath solu-
tion to give a final TTX concentration of 300 nM. Data
were acquired 20 s after TTX was added.
Data analyses
The Na+ current was recorded from neurons with capaci-
tance ≤45 pF (diameters between 15 and 30 μm) [11, 29, 30].
Current voltage (I-V) relations were fitted with the equation
IðVmÞ ¼ Gmax  ðVm−VrÞ
1þ eðV 1=2−VmÞ=k ð1Þ
where I (Vm) is the current for a given membrane poten-
tial (Vm), Vr is the reversal potential, Gmax is the max-
imum conductance, V1/2 is the half activation potential
and κ is the slope factor. The normalized conductance
was obtained by the G/Gmax ratio. Steady state inactiva-
tion curves were fitted with the equation
h∞ ¼ 11þ e Vm−Vhð Þ=kh ð2Þ
where Vh is the half inactivation potential and κh is
the slope of the steady state inactivation curve. The
window current probability graph was obtained by the
product between the equations for the steady state
Table 1 Comparison of glycemia levels (mg/dl of blood) between Control and Diabetic rats
n day 0 day 15 day 30 day 45 day 60
Control 24 95.4 ± 4.2 127.8 ± 2.0 127.5 ± 2.0 113.8 ± 1.8 117.9 ± 1.7
Diabetic 22 87.8 ± 3.4 432.8 ± 29.3* 514.0 ± 18.3* 546.7 ± 21.2* 550.7 ± 10.6*
p value 0.6687 < 0.001 < 0.001 < 0.001 < 0.001
*Significant by Two Way ANOVA test, followed by Bonferroni (control vs diabetic)
Table 2 Comparison of mechanical thresholds (g) between Control and Diabetic rats
day 0 day 15 day 30 day 45 day 60
Control 145.4 ± 3.3 n = 19 179.3 ± 2.5 n = 19 200.2 ± 4.3 n = 18 210.1 ± 3.8 n = 18 212.1 ± 5.9 n = 18
Diabetic 141.8 ± 3.6 n = 29 135.1 ± 4.5* n = 28 135.3 ± 4.5* n = 18 133.7 ± 7.2* n = 18 116.1 ± 5.8* n = 16
p value 0.5555 < 0.001 < 0.001 < 0.001 < 0.001
*Significant by Two Way ANOVA test, followed by Bonferroni (control vs diabetic)
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activation and the steady state inactivation curve [31],
as described in Eq. 3.
p ¼ 1
1þ e V 1=2−Vmð Þ=k
 1
1þ e Vm−Vhð Þ=kh ð3Þ
TTXs Na+ currents were isolated by digital subtraction
between total Na+ current and TTXr Na+ current, the
latter obtained by the use of TTX.
Table 3 Comparison of TNF-α serum concentration (pg/ml)
between Control and Diabetic rats
day 0 day 60
Control 343.0 ± 30.3 n = 3 340.3 ± 15.9 n = 7
Diabetic 314.2 ± 18.2 n = 3 624.9 ± 97.8* n = 7
p value 0.9031 0.0109
*Significant by One Way ANOVA test, followed by Bonferroni (control
vs diabetic)
Fig. 2 Effects of TNF-α exposure on sodium current amplitude in DRG neurons Representative trace of the total sodium current recorded from
cells with and without exposure to TNFα (a), along with their normalized current density-voltage relations (b). c Peak current density values for
the total sodium current with and without exposure to TNF-α. d, e, f same as in panels a-c but for the TTXs sodium current component. g, h, i
same as in panels a-c but for the TTXr sodium current component. For panels c, f and i, peak currents were measured at − 5 mV. * Total sodium
current vs total sodium current after exposure to TNF-α, # TTXs sodium current vs TTXs sodium current after exposure to TNF, § TTXr sodium
current vs TTXr sodium current after TNF exposure - p < 0.05; One Way ANOVA test followed by Bonferroni. For panels b, e and h, * Total sodium
current vs total sodium current after exposure to TNF-α, # TTXs sodium current vs TTXs sodium current after exposure to TNF, § TTXr sodium
current vs TTXr sodium current after TNF exposure - p < 0.05; Two Way ANOVA test followed by Bonferroni
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Fig. 3 Effects of TNF-α exposure on sodium current gating in DRG neurons (e) Steady state activation and inactivation curves for the total
sodium current recorded from cells with and without TNF-α exposure (b) Comparison of the half-activation and half-inactivation potential for
total sodium current. c, d same as in panels a and b, but for the TTXs sodium current component. e, f same as in panels a and b, but for the
TTXr sodium current component. * Total sodium current vs total sodium current after exposure to TNF-α, # TTXs sodium current vs TTXs sodium
current after exposure to TNF, § TTXr sodium current vs TTXr sodium current after TNF exposure - p < 0.05; One Way ANOVA test followed
by Bonferroni
Table 4 Comparison of the peak current density values (pA/pF) at a test potential of − 5 mV between the INa Total, INa TTXs and
Ina TTXr with and without TNF-α
INa Total INa TTXs INa TTXr
Control − 134.7 ± 30.3 n = 8 −89.7 ± 21.9 n = 5 − 58.2 ± 8.4 n = 8
+ TNF − 227.9 ± 29.2* n = 14 − 177.0 ± 29.8* n = 11 −95.9 ± 14.7* n = 12
p value < 0.001 0.0027 0.0044
*Significant by One Way ANOVA test, followed by Bonferroni (control vs TNF)
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Statistics
One- and two-way analysis of variance followed by
Bonferroni tests was used for multiple comparisons as
stated in the figure legends. Statistical significance
was set at 0.05.
Results
Diabetic rats develop hyperalgesia and increasing in TNF-
α serum concentration
Induction of diabetes by intraperitoneal (i.p.) STZ injec-
tion resulted in sustained hyperglycemia of diabetic rats
for at least 60 days (Fig. 1a and Table 1). Concomitantly,
the mechanical withdrawal thresholds of diabetic rats pro-
gressively decreased over the course of 60 days, whereas
those of the control group showed a progressive increase
over this time period, altogether indicating behavioral
sensitization of the diabetic group (Fig. 1b and Table 2).
We also assessed the TNF-α serum concentration of STZ
treated and control rats. On day 60, the diabetic rats
showed an elevation in TNF-α serum concentration level
(Control, 340.3 ± 16.0 pg/ml vs Diabetic, 624.9 ± 97.8 pg/
ml, day 60, Fig. 1c and Table 3).
TNF-α induces modulation of DRG neurons Na+ channels
As shown by Tamura et al. [16], adrenal chromaffin cells
achieved maximum Nav1.7 protein expression after 6
hour exposure to 100 ng/ml TNF-α. Based on the findings
of Fig. 1c and Table 3, the physiologically relevant TNF-α
concentration (700 pg/ml) was added to the medium of
dissociated DRG neurons for 6 hours. After 6 h of TNF-α
exposure, the total Na+ current, as well as its TTXs and
TTXr currents components were determined (Fig. 2).
TNF-α induced an increase in the total Na+ current dens-
ity in DRG neurons, as well as that of both the TTXs and
TTXr components (Fig. 2c, f, j, and Table 4). In addition,
total Na+ and TTXs currents appeared to activate at more
negative voltages after TNF-α exposure, as evident from a
leftward shift in the IV relation (Fig. 2b, e, h) and corre-
sponding steady state activation curves (Fig. 3a, c, e, and
Table 5), leading to a significantly more hyperpolarized
half-activation voltage (Fig. b, d, f, and Table 6).
An analysis of steady state inactivation properties
showed that the TTXs and TTXr currents respond dif-
ferently to TNF-α exposure. There was a leftward shift
in the steady state inactivation curves for the total Na+
and TTXs currents, leading to a more hyperpolarized
half-inactivation potential (Fig. 3a, c, e and Fig. 3b, d, f)
that was not observed with TTXr currents. A calculation
of the product of the activation and steady-state inacti-
vation relationships reveals the impact of the TNF-α in-
duced shifts on sodium window current (Fig. 4). TNF-α
treatment slightly reduced total Na+ window current
probability (Fig. 4a). Analyzing TTXs (Fig. 4b) and TTXr
(Fig. 4c) components revealed that TNF-α treatment
promoted both an increase in the peak and a slight left-
ward shift of the TTXs window current probability,
whereas a reduction in TTXr window current probability
is observed.
Altogether, these data indicate that a concentration of
TNF-α equivalent to that seen in diabetic produces a
gain of function predominantly in TTXs sodium cur-
rents of DRG neurons.
CRMP2 SUMOylation is not involved in TNF-α mediated
increases in NaV1.7 membrane expression
Previous work has shown that CRMP2, in its SUMOylated
form, is a potent regulator of Na+ channel membrane
localization in the primary afferent pain pathway [21–24].
Table 5 Comparison of the slope factor (k) values (mV) for steady state activation and steady state inactivation curves with and
without TNF-α
steady state activation k factor steady state inactivation k factor
INa Total INa TTXs INa TTXr INa Total INa TTXs INa TTXr
Control 7.2 ± 0.4 n = 8 6.3 ± 0.5 n = 6 6.8 ± 0.5 n = 8 − 5.1 ± 0.2 n = 7 −4.8 ± 0.2 n = 6 −5.9 ± 0.1 n = 6
+ TNF 5.3 ± 0.2* n = 14 4.8 ± 0.3* n = 11 5.3 ± 0.8 n = 15 −5.0 ± 0.3 n = 6 −4.7 ± 0.4 n = 4 −5.2 ± 0.5 n = 4
p value < 0.001 0.0012 0.5598 0.3861 0.7267 0.2197
*Significant by One Way ANOVA test, followed by Bonferroni (control vs TNF)
Table 6 Comparison of the V50 and Vh values (mV) for steady state activation and steady state inactivation curves with and without
TNF-α
V1/2 Vh
INa Total INa TTXs INa TTXr INa Total INa TTXs INa TTXr
Control −7.7 ± 0.5 n = 8 −9.9 ± 0.6 n = 6 − 9.6 ± 0.6 n = 8 −19.7 ± 0.2 n = 7 −20.8 ± 0.3 n = 6 −18.3 ± 0.2 n = 6
+ TNF −12.9 ± 0.2* n = 14 −15.3 ± 0.3* n = 11 −10.7 ± 0.9 n = 15 −23.0 ± 0.4* n = 6 −23.1 ± 0.5* n = 4 − 19.6 ± 0.5 n = 4
p value < 0.001 < 0.001 0.2589 < 0.001 0.0052 0.4003
*Significant by One Way ANOVA test, followed by Bonferroni (control vs TNF)
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To determine whether TNF-α acts through this pathway,
the total Na+ current was recorded from dissociated DRG
neurons infected with AAV5 constructs encoding a
CRMP2 SUMO-incompetent mutant protein, CRMP2-
K374A-GFP. Control cells were infected with wild type
CRMP2-GFP-AAV5 (Fig. 5). After being kept in culture for
2 weeks, the infected DRG neurons exhibited strong ex-
pression of the various CRMP2-GFP constructs (Fig. 5a-d)
and robust NaV currents (Fig. 6a). DRG neurons infected
with CRMP2-WT exhibited total Na+ current density
values (− 89.4 ± 9.3 pA/pF) similar to that obtained in
non-infected (control) DRG neurons (− 94 ± 19.6 pA/pF,
Fig. 6b, g, and Table 7). DRG neurons expressing CRMP2-
K374A showed reduced total Na+ current density (−
49.2 ± 5.3 pA/pF) when compared to both the control cells
and CRMP2-WT cells (Fig. 6c, d, g and Table 7). After ex-
posure to TNF-α, CRMP2-WT expressing cells showed a
40% increase in total Na+ current density (− 137.6 ± 19
pA/pF) (Fig. 6f, g and Table 7). TNF-α treatment in-
creased total Na+ current density in CRMP2-K374A ex-
pressing cells by about 50% (− 76 ± 9.9 pA/pF) (Fig. 6e, g
and Table 7). Hence, we conclude that interfering with
CRMP2 SUMOylation does not preclude TNF-α mediated
increases in Na+ current density.
Discussion
It has been shown that the elevation in basal glycemia is
capable of promoting an increase in plasma TNF-α con-
centration, even in healthy non-diabetic individuals.
In experiments performed in cell culture, hypergly-
cemic medium stimulates inflammatory signaling
pathways that activate nuclear factor-κB (NF-κB) [32–
34]. This may promote the transcription of TNF-α
and its insertion into the endocrine/paracrine cycle
signaling linked to TNF-α release, followed by new
activation of NF-κB [35]. Li et al. [36] showed in cell
cultures that hyperglycemic medium induces the ex-
pression of the metalloproteinase ADAM-17 which is
consistent with the ensuing elevation in TNF-α serum
concentration. There are also clinical findings that as-
sociate pro-and anti-inflammatory cytokine elevation
in the blood serum with the induction and persist-
ence of DNP in diabetic patients [37–39]. Ortmann
and Chattopadhyay [40] highlighted the importance of
TNF-α as an additional pathogen in the development
of diabetic neuropathy. These authors showed in-
creased immuno-reactivity for TNF-α in histological
sections of the DRG, dorsal horn of the spinal cord,
sciatic nerve and paw skin of rats that developed
hyperalgesia [41]. Several studies have correlated the
elevation in plasma TNF-α concentration with alter-
ation of the expression and/or function of voltage-
dependent Na+ channels, critical elements in the es-
tablishment of neuronal excitability. In turn, this may
be reflected, at least in part, in the reduction of the
threshold for activation of the peripheral nerves, thus
promoting the establishment of chronic neuropathic
pain [42–46]. Thus, our data are in accordance with
previous findings, since diabetic rats, with sustained
hyperglycemia, exhibited both hyperalgesia and ele-
vated TNF-α serum concentration levels.
Hyperalgesia to mechanical stimuli has been exten-
sively reported in STZ-induced diabetic rats [47–50],
and the data represented in Fig. 1 are in agreement
with the literature. Like others [51–56], we observed
an age-dependent increase in mechanical thresholds
in control rats, whereas STZ injected rats showed a
Fig. 4 Analysis of window currents. Window current probability
obtained from the activation and inactivation curves depicted in Fig.
2 for the effect of TNF-α exposure on (a) the total sodium window
current, (b) the TTXs sodium window current and (c) the TTXr
sodium current vs TTXr sodium window current
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slight decrease, overall consistent with the develop-
ment of diabetic neuropathic pain. In diabetic rats
with hyperalgesia, DRG neurons are known to exhibit
increased action potential frequency in response to
sustained suprathreshold mechanical stimulation [47,
57, 58] and increased spontaneous activity [59]. Both
effects are thought to contribute to the development
of pain [43] and are related to the activity of voltage-
activated Na+ channels. Among these Na+ channels,
the NaV1.7 isoform has been associated with a crucial
role in the development of the DNP. NaV1.7 channels
are robustly expressed in the cell bodies of virtually
all neurons that act as nociceptive fibers Aδ and C
[19, 60]. They are also present in both peripheral and
central termini, with expression in the intraepidermal
nerve fibers within the skin and dorsal root horn sur-
face lamina, the region of greatest synaptic connectiv-
ity between primary and secondary nociceptive
neurons [25]. Nav1.7 expression is increased in
diabetic rats [11, 20, 61] and this effect has been
linked to TNF-α expression in the DRG of these ani-
mals [61]. Based on this and in the work of Tamura
et al. [16], we investigated how exposure of dissoci-
ated DRG neurons to relevant TNF-α concentrations
may affect their Na+ currents.
Our results showed that TNF-α induces an increase of
both TTXs and TTXr current density, which contributes
to the overall increase in total Na+ current. Ding and col-
leagues reported a TNF-α mediated increase in Nav1.6 ex-
pression in rat DRG neurons [62], whereas Chen et al.
[63] observed no change in the expression of the Na+
channel isoforms NaV1.1, 1.2, 1.3 or 1.6 in response to 8 h
exposure to a TNF-α concentration of 1000 pg/ml. On the
other hand, NaV1.7 was shown to increase its expression
after only 6 h exposure to the same concentration of TNF-
α [16]. Although other groups reported differences in
total, TTXs or TTXr currents after a shorter duration of
TNF-α exposure, this can be explained by the notion that
Fig. 5 Confocal microscopy images taken from dissociated DRG neurons 2 weeks after viral infection (a) Examples of DRG neurons expressing the
CRMP2-WT tagged with GFP. b DRG neurons expressing the CRMP2-K374A with a GFP tag. c and d. Images of axons arising from DRG neuron
cells bodies expressing CRMP2-WT-GFP and CRMP2-K374A-GFP, respectively
Macedo et al. Molecular Brain          (2019) 12:117 Page 9 of 14
Fig. 6 (See legend on next page.)
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these authors used much higher TNF-α concentrations
[28, 64, 65]. It is important to note that NaV1.7 is the main
Na+ channel isoform expressed in Aδ and C fibers [66,
67], and hence it is thus possible that our observed
changes in the TTXs Na+ current occurred are due to an
increase in NaV1.7 expression. Further experimentation
will be needed to attribute the expression of specific Nav
isoforms confirm to our whole cell recordings.
We also observed a functional effect of TNF-α on
the activation gating of the TTXs current component,
an effect not seen with the TTXr Na+ current. A pos-
sible mechanism by which TNF-α alters the gating of
TTXs channels may be through the ERK1 and ERK2
kinase phosphorylation and perhaps via p38 MAPK,
both of which are activated by TNF receptors [21, 23,
68]. The latter mechanism has been reported to aug-
ment NaV1.8 single channel conductance [28, 59, 63],
which would match the increased current density of
the TTXr current. Increases in Nav1.8 and Nav1.9 ex-
pression in transgenic mice with elevated TNF-α
levels have also been reported [31]. Indeed, we note
that the TTXr Na+ current observed in our experi-
ments may be carried by NaV1.8 channels, since the
pipette solution does not contain CsF (or even F−),
necessary for the recording of the Na+ current con-
ducted by the NaV1.9 isoform [69]. As noted above, a
detailed dissection at the molecular level will be
needed to validate such a possibility.
The mechanism by which TNF-α induces the in-
crease in NaV1.7 channel expression has not yet been
clarified. Recently, Dustrude et al. [70] demonstrated
that NaV1.7 expression in the cell membrane can be
modulated by the cytoplasmic protein CRMP2. This
protein is highly expressed in neurons and oligoden-
drocytes of the central nervous system [47]. During
central nervous system development, this protein also
performs regulatory and structural functions related
to cytoskeletal dynamics, vesicle traffic and synaptic
activity, while its functions in the adult brain are still
being elucidated. In addition, CRMP2 has been corre-
lated with various neuropathological or psychiatric
conditions, including Alzheimer’s disease and schizo-
phrenia [71]. CRMP2 can be phosphorylated at sev-
eral sites, SUMOylated, undergo addition of a β-N-
acetyl-D-glucosamine group and be oxidized [72].
Among these, SUMOylation is a covalently reversible
binding process between small ubiquitin-like modify-
ing proteins (SUMO1, 2 or 3) and the substrate. Ac-
cording to the work of Dustrude et al. [70], inhibition
of CRMP2 SUMOylation in DRG neurons reduces
NaV1.7 channels trafficking from the nucleus to the
cellular membrane surface. Moreover, depletion of
(See figure on previous page.)
Fig. 6 Sodium currents in DRG neurons expressing CRMP2 and its mutants. a Representative traces recorded from a non-transfected DRG neuron
(control), of the total sodium current recorded from DRG neurons expressing CRMP2-WT-GFP or CRMP2-K374A-GFP without exposure to TNF-α
and after being exposed to TNFα for 6 h. b-f comparisons of the current density-voltage relationships for the total sodium current recorded from
control, CRMP2-WT and CRMP2-K374A neurons. For panels (b) and (c), the control group is compared to CRMP2-WT and CRMP2-K374A groups,
respectively. For panels (d) and (e), the CRMP2-K374A group is compared to CRMP2-WT and CRMP2-K374A + TNF-α groups, respectively. For
panel (f), all previous groups are depicted, and the CRMP2-WT + TNFα group is added. § control vs CRMP2 WT + TNFα; * control vs CRMP2-K374A;
@ CRMP2 WT vs CRMP2-K374A; # CRMP2-K374A vs CRMP2-K374A + TNFα. §, *, @ and #, p < 0.05; Two Way ANOVA test followed by Bonferroni. g
shows the current density peak values measured at − 5 mV for all of the studied groups. *, # and §, p < 0.05; One Way ANOVA test followed by
Bonferroni. n reflects numbers of cells. + TNF reflects 6 h TNF-α exposure
Table 7 Comparison of peak current density (pA/pF), at a test potential of − 5 mV, recorded from Control cells and cells expressing
various CRMP2 constructs with and without exposure to TNF-α
Control CRMP2 WT CRMP2-K374A CRMP2 WT + TNF-α CRMP2-K374A + TNF-α p value
−93.6 ± 19.6 n = 15 − 89.4 ± 9.2 n = 17 – – – 0.6722
−93.6 ± 19.6 n = 16 – − 49.2 ± 5.2* n = 19 – – < 0.001
−93.6 ± 19.6 n = 17 – – − 137.6 ± 18.9* n = 15 – < 0.001
−93.6 ± 19.6 n = 18 – – – − 76.0 ± 9.8 n = 11 0.1420
– − 89.4 ± 9.2 n = 17 −49.2 ± 5.2* n = 19 – – < 0.001
– − 89.4 ± 9.2 n = 17 – − 137.6 ± 18.9* n = 15 – < 0.001
– − 89.4 ± 9.2 n = 17 – – − 76.0 ± 9.8 n = 11 0.2566
– – − 49.2 ± 5.2 n = 19 −137.6 ± 18.9* n = 15 – < 0.001
– – −49.2 ± 5.2 n = 19 – − 76.0 ± 9.8 n = 11 0.0245
– – – − 137.6 ± 18.9 n = 15 −76.0 ± 9.8* n = 11 < 0.001
*, p < 0.05; One Way ANOVA test followed by Bonferroni
(−) indicates that the respective group is not part of the comparison on that row
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CRMP2 leads to a reduction in the Na+ current density
via NaV1.7. In our hands, DRG neurons expressing the
CRMP2-K374A protein showed reduced total Na+ current
density when compared to both the control group neu-
rons and neurons expressing the CRMP2-WT protein, in
agreement with the work of Dustrude et al. [70]. Nonethe-
less, TNF-α potentiated TTXs currents in the presence of
either WT or mutant CRMP2, indicating that TNF-α ef-
fects occur independently of CRMP2. Further work will be
required to define the precise cell signaling pathways that
underlie the action of TNF-α on Na+ channels in sensory
afferents.
In conclusion, TNF-α, at a serum concentration simi-
lar to that measured in STZ-induced diabetic rats, is
capable of modulating Na+ current in dissociated DRG
neurons after 6 h exposure. Although this effect is inde-
pendent of SUMOylation of CRMP2, the TNF-α medi-
ated enhancement of Na+ channel expression could
potentially be exploited for therapeutic intervention into
diabetic pain.
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